Jamarcus Brider
Cardiovascular Disease · Chattanooga, TNNPI 1497383806
Payments from drug & device makers
Across 115 payments — averaging $44.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$1K
- Abbott$406
- Shockwave Medical, Inc$392
- E.r. Squibb & Sons, L.L.C.$379
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$325
- Boston Scientific$297
- plus $2K from 24 others
What the payments were for
- Food & beverage$4,99097%
- Education$1313%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 20 | $1,371 |
| Abbott | 9 | $406 |
| Shockwave Medical, Inc | 3 | $392 |
| E.r. Squibb & Sons, L.L.C. | 9 | $379 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 16 | $325 |
| Boston Scientific | 3 | $297 |
| Pfizer | 13 | $232 |
| Scpharmaceuticals Inc. | 4 | $214 |
| Cvrx, Inc. | 3 | $213 |
| Kestra Medical Technology Services, Inc. | 4 | $197 |
| Amgen | 2 | $161 |
| Inari Medical, Inc. | 1 | $145 |
| Stryker | 1 | $144 |
| Edwards Lifesciences | 2 | $124 |
| Boehringer Ingelheim | 4 | $62 |
| Medtronic | 1 | $57 |
| BD | 2 | $53 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $46 |
| Lexicon Pharmaceuticals, Inc. | 2 | $45 |
| AstraZeneca | 3 | $44 |
| Johnson & Johnson | 2 | $43 |
| Lantheus Medical Imaging, Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Cardiva Medical, Inc. | 1 | $20 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $19 |
| Novartis | 1 | $19 |
| Philips North America LLC | 1 | $15 |
| Olympus America Inc. | 1 | $14 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$301
- Impella$273
- Barostim Neo System$150
- FLOWTRIEVER CATHETER, S$145
- CT THROMBECTOMY SYSTEM KIT$145
- FlowTriever$144
- Assure WCD$134
- ENSITE$131
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$122
- FUROSCIX$109
- WATCHMAN FLX$107
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$103
- CAMZYOS$101
How this compares
$5,122 in reported general payments places this provider in the 60th percentile of 429 cardiovascular disease providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 29 | $14,922 |
| EliquisApixaban | 14 | $14,718 |
| FarxigaDapagliflozin Propanediol | 20 | $11,505 |
| Rosuvastatin Calcium | 55 | $456 |
| Metoprolol Succinate | 32 | $401 |
| Losartan Potassium | 23 | $145 |
| ClopidogrelClopidogrel Bisulfate | 37 | $137 |
| Spironolactone | 15 | $116 |
| Furosemide | 15 | $69 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBrilinta, Farxiga | $44 | $26,42749 claims |
| PfizerEliquis | $232 | $14,71814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 429 cardiovascular disease providers in Tennessee.
Other cardiovascular disease in Chattanooga
- Selcuk TombulChattanooga$204K
- Patrick StevensChattanooga$103K
- Brian LindmanNashville$5.5M
- David MetzgerKingsport$4.8M
- Christopher EllisNashville$4.1M
- Dinesh GuptaNashville$3.2M
- Joann LindenfeldNashville$2.2M
- Frank McGrewMemphis$2.1M
- Rebecca HungNashville$1.8M
- Mohsin AlhaddadJackson$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.